Better Choice Company signs binding LOI to acquire Choice Specialty

Better Choice Company (BTTR) announced that it has signed a binding Letter of Intent, LOI to acquire 100% of Choice Specialty Pharmacy Group, a fully licensed and prominent provider of specialized pharmacy services in the U.S., through an option purchase agreement. This acquisition is expected to further strengthen Better Choice’s specialty pharmacy presence in the U.S. and the purchase price is based on 6X of Seller’s FY2024 Adjusted EBITDA1 of approximately USD $4.68 million, and consideration will be comprised of stock and cash at closing.